April 22 (Reuters) - Telehealth company Hims & Hers said on Wednesday it will now offer treatment options for perimenopause and menopause via its platform, as rising U.S. demand for hormone therapy ...

The telehealth company said it had secured sufficient inventory to allow eligible patients to begin or continue treatment ...

Estrogen patches, one of the most popular menopause treatments, have been in short supply this year. Now the FDA is working ...

“Try different brands and warn other women, because it's real,” the comedian said on social media ...

If you’re having a hard time getting your estrogen patch prescription filled, you’re not alone. In some parts of the country, ...

Fact checked by Jennifer Klump Key Takeaways The FDA has removed the black box warning on hormone therapy, which had ...

With demand up 86% since 2021 and supplies dwindling, women are turning to alternative hormone treatments and creative ...

A surge in demand since last year for estrogen patches to ease menopause symptoms has strained supplies and led to shortages, sparking a scramble for medicines that industry sources say could last up ...

After years of being a controversial way of treating symptoms of menopause, hormone therapy is making a comeback. That’s due to a wide range of factors, including a large body of data that shows how ...

Manufacturers report estrogen patch shortage as the demand for them outpaces the supply for women looking for relief from ...

There’s a growing shortage of hormone replacement therapy drugs. For many, those prescription patches, pills and creams have ...